Search research articles
Contact Us
Filters
Showing results (341-350 of 383) with videos related to
Page
of 39
Sort By:
The European Respiratory Journal
|
June 11, 2026
ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults
Markus Fally, Catia Cilloniz, John Linnell, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study
Jason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in <i>Anopheles</i> mosquitos while reducing their lifespan and malaria parasite burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Nature Communications
|
August 27, 2025
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos reducing their lifespan and malaria burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Research Square
|
November 1, 2024
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in <i>Anopheles</i> mosquitos while reducing their lifespan and malaria parasite burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Infectious Diseases and Therapy
|
June 12, 2026
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study
Dominik Jarczak, Stefan Kluge, Martin Kieninger, et al.
Intensive Care Medicine
|
February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study
Jason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
Cell Reports. Medicine
|
November 20, 2024
Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response
Rachel Brandes-Leibovitz, Anca Riza, Gal Yankovitz, et al.
Journal of Intensive Medicine
|
January 24, 2024
Epidemiology and risk factors for mortality in critically ill patients with pancreatic infection
Marie Dejonckheere, Massimo Antonelli, Kostoula Arvaniti, et al.
Intensive Care Medicine
|
October 31, 2019
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project
Stijn Blot, Massimo Antonelli, Kostoula Arvaniti, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 383) with videos related to
Sort By:
Page
of 39
The European Respiratory Journal
|
June 11, 2026
ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults
Markus Fally, Catia Cilloniz, John Linnell, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
October 25, 2023
A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study
Jason A Roberts, Fekade Sime, Jeffrey Lipman, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2025
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in <i>Anopheles</i> mosquitos while reducing their lifespan and malaria parasite burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Nature Communications
|
August 27, 2025
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos reducing their lifespan and malaria burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Research Square
|
November 1, 2024
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in <i>Anopheles</i> mosquitos while reducing their lifespan and malaria parasite burden
Emma Camacho, Yuemei Dong, Christine Chrissian, et al.
Infectious Diseases and Therapy
|
June 12, 2026
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study
Dominik Jarczak, Stefan Kluge, Martin Kieninger, et al.
Intensive Care Medicine
|
February 3, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study
Jason A Roberts, Fekade B Sime, Jeffrey Lipman, et al.
Cell Reports. Medicine
|
November 20, 2024
Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response
Rachel Brandes-Leibovitz, Anca Riza, Gal Yankovitz, et al.
Journal of Intensive Medicine
|
January 24, 2024
Epidemiology and risk factors for mortality in critically ill patients with pancreatic infection
Marie Dejonckheere, Massimo Antonelli, Kostoula Arvaniti, et al.
Intensive Care Medicine
|
October 31, 2019
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project
Stijn Blot, Massimo Antonelli, Kostoula Arvaniti, et al.
Page
of 39